Filing Details
- Accession Number:
- 0000904454-19-000073
- Form Type:
- 13G Filing
- Publication Date:
- 2019-01-22 11:39:07
- Filed By:
- Johnson & Johnson
- Company:
- Macrogenics Inc (NASDAQ:MGNX)
- Filing Date:
- 2019-01-22
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Johnson Johnson EIN | 0 | 1,923,077 | 0 | 1,923,077 | 1,923,077 | 4.6% |
| Johnson Johnson Innovation-JJDC, Inc. EIN | 0 | 1,923,077 | 0 | 1,923,077 | 1,923,077 | 4.6% |
Filing
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| SCHEDULE 13G |
| (Rule 13d-102) |
| INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT |
| TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED |
| PURSUANT TO RULE 13d-2(b) |
| (Amendment No. 1)1 |
| MacroGenics, Inc. |
| (Name of Issuer) |
| Common Stock, $.01 par value |
| (Title of Class of Securities) |
| 556099109 |
| (CUSIP Number) |
| December 31, 2018 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
1 The remainder of this cover page shall be filled out
for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all
other provisions of the Act.
| 1. | NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Johnson & Johnson EIN: 22-1024240 | |||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [ ] (b) [ ] | ||
| 3. | SEC USE ONLY | |||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER -0- | ||
| 6. | SHARED VOTING POWER 1,923,077* | |||
| 7. | SOLE DISPOSITIVE POWER -0- | |||
| 8. | SHARED DISPOSITIVE POWER 1,923,077* | |||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,923,077* | |||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | [ ] | ||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.6% ** | |||
| 12. | TYPE OF REPORTING PERSON CO | |||
* As of December 31, 2018.
** Based on 42,259,080 shares of Common Stock outstanding as of November 2, 2018, as reported in the Issuer’s Report on Form 10-Q for the period ended
September 30, 2018 filed with the Securities and Exchange Commission on November 7, 2018.
CUSIP No. 556099109
| 1. | NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Johnson & Johnson Innovation-JJDC, Inc. EIN: 22-2007137 | |||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [ ] (b) [ ] | ||
| 3. | SEC USE ONLY | |||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER -0- | ||
| 6. | SHARED VOTING POWER 1,923,077* | |||
| 7. | SOLE DISPOSITIVE POWER -0- | |||
| 8. | SHARED DISPOSITIVE POWER 1,923,077* | |||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,923,077* | |||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | [ ] | ||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.6% ** | |||
| 12. | TYPE OF REPORTING PERSON CO | |||
* As of December 31, 2018.
** Based on 42,259,080 shares of Common Stock outstanding as of November 2, 2018, as reported in the Issuer’s Report on Form 10-Q for the period ended
September 30, 2018 filed with the Securities and Exchange Commission on November 7, 2018.
CUSIP No. 556099109
AMENDMENT NO. 1 TO
SCHEDULE 13G (FINAL AMENDMENT)
Reference is hereby made the statement on Schedule 13G filed with
the Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on February 5, 2015 (the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.
The following items of the Schedule 13G are amended and restated to read in their entirety as follows:
| ITEM 1(b) | ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: | ||
| 9704 Medical Center Drive, Rockville, MD 20850 | |||
| ITEM 2(b) | ADDRESS OF PRINCIPAL BUSINESS OFFICE: | ||
| J&J: One Johnson & Johnson Plaza, New Brunswick, NJ 08933 JJDC: 410 George Street, New Brunswick NJ 08901 | |||
| ITEM 4 | OWNERSHIP: (a) through (c) The information set forth in the cover pages to this Amendment No. 1 to Schedule 13G is incorporated herein by reference thereto. | ||
| ITEM 5 | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: If this statement is being filed to report the fact that the Reporting Persons have ceased to be beneficial owners of more than five percent of
the Common Stock, check the following: [X]. | ||
CUSIP No. 556099109
SIGNATURE
After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is
true, complete and correct.
Dated: January 22, 2019
| JOHNSON & JOHNSON | |||
| By: | /s/ Thomas Spellman III | ||
| Name: | Thomas Spellman III | ||
| Title: | Secretary | ||
| JOHNSON & JOHNSON INNOVATION-JJDC, INC. | |||
| By: | /s/ Kevin Norman | ||
| Name: | Kevin Norman | ||
| Title: | Assistant Secretary | ||